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LETTER TO THE EDITORThe need for a validated pathway for the diagnosis
and management of prosthetic vascular graft
infection
Prosthetic vascular graft infection (PVGI) is a serious compli-
cation of both aortic and peripheral vascular procedures. Occurring
in 1% to 6% of all prosthetic vascular graft procedures, it is associ-
ated with mortality rates of 20% in aortic PVGI1 and limb ampu-
tation rates of up to 70% in peripheral PVGI.2 Early diagnosis is
a prerequisite to correct management. Although a number of clin-
ical, microbiologic, and radiologic investigations have been shown
to be useful in the diagnosis of PVGI, there is still a paucity of pro-
spective data for the development of a clear pathway for the diag-
nosis and management of PVGI.2 A variable presentation and lack
of high-level evidence on this subject1 mean that there currently is
little agreement in the literature,1,3 with most cases being managed
on an individual basis, varying between centers.
Diagnostic criteria, similar to the Duke criteria for infective
endocarditis, have been proposed by FitzGerald et al.4 These
include positive microbiologic cultures, clinical signs of infection,
and biologic or radiologic signs of graft infection.4 However, this
has not been validated because of the difﬁculty in recruiting large
enough numbers of subjects in a single center to adequately power
such a study.4
Given the lack of high-level evidence, patients should be
managed at specialist centers with multidisciplinary input from
vascular surgery, infectious disease, microbiology, and nuclear
medicine teams.2,4 Isolation of causative organisms should be a pri-
ority, ideally while the patient is not receiving antimicrobial
chemotherapy. Radiologic investigation should include contrast-
enhanced computed tomography aortography as a ﬁrst-line investi-
gation.1 Surgical treatment can include graft preservation surgery,
complete graft excision, or conservative medical management
when the patient is not suitable for further surgical intervention.1
As most PVGIs are polymicrobial, predominantly containing anaer-
obes and bioﬁlm producers, such as staphylococcal species,1 empir-
ical antimicrobial treatment should be broad. However, up to 60%
of cases are microbial culture negative.1 This is likely to be inﬂu-
enced by preceding antimicrobial treatment and the collection of
only single, peripheral blood samples.1,2,4 From experience of man-
aging prosthetic heart valve and orthopedic infections, antimicro-
bials with good bioﬁlm penetration and high oral bioavailability
should be considered (eg, rifampicin).1,2,4 Length of antimicrobial
treatment varies greatly between individual centers.
The lack of implementation of large, multicenter, prospective,
longitudinal studies run by multidisciplinary experts is putting pa-
tients with PVGI at risk of late diagnosis and therefore poorer out-
comes. Work is needed to create and to validate a clear pathway forthe diagnosis and management of PVGI. As a center with a
specialist vascular surgery and infectious disease unit, we are
currently in the process of describing our experience of managing
PVGI, many of which are often referred from other centers. We
aim to produce a diagnostic and management algorithm that can
then be audited to assess its effectiveness. We also propose the cre-
ation of a multicenter database, much like the National Vascular
Database, to allow the prospective collection of microbiologic,
radiologic, and surgical data as well as documentation of long-
term outcomes for patients with PVGI.
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